Tinnitus News and Research RSS Feed - Tinnitus News and Research

Tinnitus is a disorder in which a person hears noises such as buzzing, ringing, clicking, or the sound of a pulse, when no outside sound is causing them. Tinnitus may have many different causes, and may be a symptom of another disease or condition. It may be caused by certain tumors and anticancer drugs.
Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Tinnitus, migraine, epilepsy, depression, schizophrenia, Alzheimer's: all these are examples of diseases with neurological causes, the treatment and study of which is more and more frequently being carried out by means of magnetic stimulation of the brain. However, the method's precise mechanisms of action have not, as yet, been fully understood. [More]
ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Chronic tinnitus is a disabling disorder. A new study published in the current issue of Psychotherapy and Psychosomatics reports on a therapy that is performed over internet. [More]
Research examines evidence of damage to hearing

Research examines evidence of damage to hearing

New research examines evidence of damage to your hearing. Many people listen to loud music without realizing that this can affect their hearing. [More]
Higher caffeine intake associated with lower rates of tinnitus

Higher caffeine intake associated with lower rates of tinnitus

New research from Brigham and Women's Hospital (BWH) finds that higher caffeine intake is associated with lower rates of tinnitus, often described as a ringing or buzzing sound in the ear when there is no outside source of the sounds, in younger and middle-aged women. [More]
Integrated therapies can reduce depression by half among people with low vision due to AMD

Integrated therapies can reduce depression by half among people with low vision due to AMD

The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD). [More]
Patient goes on fishing trip after undergoing complex brain surgery

Patient goes on fishing trip after undergoing complex brain surgery

Just two weeks after undergoing delicate and complex brain surgery for a life-threatening condition, Bill Abt's surgeon cleared him to take a previously scheduled fishing trip. [More]
Tinnitus patients process emotions differently in brain from those with normal hearing

Tinnitus patients process emotions differently in brain from those with normal hearing

Patients with persistent ringing in the ears - a condition known as tinnitus - process emotions differently in the brain from those with normal hearing, researchers report in the journal Brain Research. [More]
Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide. [More]
Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK’s innovation agency, the Technology Strategy Board. [More]
Otonomy secures $49M in oversubscribed Series D round of financing

Otonomy secures $49M in oversubscribed Series D round of financing

Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced it has secured $49 million in an oversubscribed Series D round of financing. [More]
Study sheds light on factors that lead to development of rare condition affecting inner ear

Study sheds light on factors that lead to development of rare condition affecting inner ear

A new study has shed light on the factors likely to lead to the development of a rare condition affecting the inner ear. [More]
Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections. [More]
Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions. [More]
National clinical trial to test new avenue for tinnitus treatment

National clinical trial to test new avenue for tinnitus treatment

UT Southwestern Medical Center will take part in a national clinical trial to test a device that could provide relief for people suffering from tinnitus, a persistent buzzing or ringing sound in the ears. The device uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus. [More]
Scientific Statement details latest evidence for diagnosis and treatment of fibromuscular dysplasia

Scientific Statement details latest evidence for diagnosis and treatment of fibromuscular dysplasia

A vascular disease called fibromuscular dysplasia, which can cause high blood pressure, kidney failure, stroke and other symptoms -- mostly in women -- is "poorly understood by many healthcare providers," according to a Scientific Statement from the American Heart Association. [More]
Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN (minocycline hydrochloride) Pellet-Filled Capsules. [More]
Leicester research reveals how noise damages hearing system

Leicester research reveals how noise damages hearing system

A research team investigating tinnitus, from the University of Leicester, has revealed new insights into the link between the exposure to loud sounds and hearing loss. [More]
Aspirin intake correlates with halted growth of lethal intracranial tumor

Aspirin intake correlates with halted growth of lethal intracranial tumor

Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. [More]
Study suggests potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth

Study suggests potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth

Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. [More]
Magnetoencephalography can be used to control and train specific targeted brain regions

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions. [More]